Colorimetric endotoxin sensing detection method

Through the endotoxin sensing detection reagent composed of gold nanoparticles, magnetic beads, DNA and cetyl trimethylammonium bromide, combined with a portable paper-based colorimetric sensor, the poor selectivity and portability of existing endotoxin detection methods are solved. The high-sensitivity endotoxin detection has been achieved, overcome the application limitations of large-scale equipment, and achieved the goal of accurate quantitative detection.

CN118937316APending Publication Date: 2024-11-12XUZHOU COLLEGE OF INDAL TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411068768.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing endotoxin detection methods have problems such as poor selectivity, high cost, inconvenience and prone to false positive results, especially the biosensor detection method has not been widely used in the market.

Method used

Using endotoxin sensing detection reagent composed of gold nanoparticles, magnetic beads, DNA and cetyl trimethylammonium bromide, the endotoxin content is detected through CTAB-mediated color changes, and accurate quantity detection is achieved in combination with fluorescence spectroscopy. , design a portable paper-based colorimetric sensor.

Benefits of technology

The accurate detection of endotoxin is achieved, the device is small and portable, and has high sensitivity. It overcomes the application limitations of large equipment, realizes the possibility of on-site detection, and achieves the detection effect of a minimum detection limit of 1.890μM.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004980193950000061
    Figure BDA0004980193950000061
  • Figure HDA0004980193960000011
    Figure HDA0004980193960000011
  • Figure HDA0004980193960000012
    Figure HDA0004980193960000012
Patent Text Reader

Abstract

The invention relates to an endotoxin sensing detection method, and belongs to the field of analysis and detection. The reagent consists of gold nanoparticles, magnetic beads, DNA (Deoxyribose Nucleic Acid) and cetyltrimethylammonium bromide, and the molar ratio of the magnetic beads to the DNA to the CTAB is (1-5): (25-50): (10-20); and the mass concentration of the gold nanoparticles is 0.02 to 0.1 mg / mL. According to the method, the content of the endotoxin is determined according to the color change of the gold nanoparticles mediated by the cationic surfactant hexadecyl trimethyl ammonium bromide on the test paper, when the endotoxin exists in a sample, under the action of the surfactant, the gold nanoparticles can be coated by the surfactant to be gathered, and the content of the endotoxin in the sample can be determined according to the color change of the gold nanoparticles mediated by the cationic surfactant hexadecyl trimethyl ammonium bromide. Due to the unique optical characteristics of the gold nanoparticles, the color of the solution is changed from red to blue at the moment. The accurate quantitative detection of the endotoxin can be realized through the combination of the shade of the color and the fluorescence spectrum. The method is high in sensitivity, the aim of accurately and quantitatively detecting the endotoxin can be achieved, and the minimum detection limit is 1.890 mu M.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of rapid testing, in particular to a colorimetric endotoxin sensing detection method, and in particular to an endotoxin sensing detection reagent and a paper-based colorimetric endotoxin sensing detection method. Background Art

[0002] In clinical practice, when a large amount of intravenous infusion is performed, if the liquid contains pyrogens, the patient will experience symptoms such as chills, high fever, sweating, fainting, and vomiting within 0.5 to 1 hour. The body temperature can reach 40°C when the fever is high, and severe cases may even go into shock. This phenomenon is called a pyrogenic reaction. The main cause of pyrogenic reactions is the contaminated pyrogens in the injection solution or infusion set. Pyrogens refer to a class of substances that can cause the body temperature to rise after being injected into the human or animal body. They can be divided into exogenous pyrogens and endogenous pyrogens. Bacterial endotoxins are the most widespread exogenous pyrogens. Endotoxins are a general term for toxic substances present in the cells of Gram-negative bacteria. They are a component of the cell walls of many Gram-negative bacteria, called lipopolysaccharides (LPS). Lipopolysaccharides are toxic to the host, and their toxic components are mainly lipid A. Although endotoxins are tightly embedded in the cell wall, they will also continuously release endotoxins to the surrounding environment. This release occurs during normal cell growth and division, cell disintegration and death. If the bacterial endotoxin content of infusion drugs and infusion medical devices is too high and enters the human blood circulation, it will cause a series of clinical reactions such as fever, hypotension, chills, etc. In severe cases, it will cause disseminated intravascular coagulation (DIC), multiple organ dysfunction syndrome, endotoxin shock, endotoxin sepsis, etc., which are life-threatening. Therefore, the rapid quantitative detection of endotoxins not only helps to identify whether it is a bacterial infection, especially for Gram-negative bacillus infection, but also has important reference value. It can also indicate the severity of the infection and can be used for rapid auxiliary diagnosis of the cause of fever; it is conducive to the early diagnosis and treatment of diseases in the clinic, provides a certain theoretical basis for the selection of medication, and dynamically monitors the condition, which is of great significance for the efficacy and prognosis after medication; it is used for the monitoring of hemodialysis fluid, which plays an important role in ensuring the treatment effect and patient safety. In short, the rapid quantitative detection of endotoxins has important practical significance for clinical symptomatic treatment.

[0003] At present, the methods for endotoxin determination include horseshoe crab reagent method, lipopolysaccharide (LPS) biological marker detection analysis method, enzyme-linked immunosorbent assay (ELISA), biosensor detection method, etc. Enzyme-linked immunosorbent assay (ELISA) is an emerging endotoxin detection method. It is an antigen-antibody based enzyme-linked immunosorbent assay, which is based on the determination of endogenous pyrogen substances such as tumor necrosis (TNF) factor interleukin 1 (IL-1) produced by macrophages stimulated by external pyrogens; biosensor detection method is also an emerging endotoxin detection method, including optical, electrochemical and fluorescent biosensors. Among them, LPS quantification is mainly based on the affinity between LPS and natural or artificial recognition molecules such as peptides, antibodies, specific aptamers, plasma nanoparticles and target molecules to achieve detection. However, due to high cost and difficulty in real-time tracking, most of the current biosensor detection methods are in the research and experimental stage and have not yet been widely used in the market.

[0004] The biosensor detection method of the prior art has the following defects:

[0005] (1) The fluorescence method has good selectivity and low detection limit, but it requires fluorescently labeled molecules or nanoparticles, and the detection device is not portable.

[0006] (2) Although chemiluminescence and electrochemical methods have certain advantages in detection sensitivity and selectivity, the chemiluminescence method has poor controllability in time and space and is prone to produce false positive results.

[0007] (3) The electrochemical method also has problems such as easy electrode contamination and high background signal-to-noise ratio.

[0008] There is no related report in the prior art on detecting endotoxin via the color change of gold nanoparticles mediated by CTAB. Summary of the invention

[0009] In order to overcome the defects of the prior art, the present invention provides an endotoxin sensing detection reagent and method, which can realize accurate quantitative detection of endotoxin.

[0010] To achieve the above object, the technical solution of the present invention is:

[0011] The present invention first provides an endotoxin sensing detection reagent, which is composed of gold nanoparticles (AuNPs), magnetic beads (MB), DNA, and cetyltrimethylammonium bromide (CTAB), wherein the molar ratio of the magnetic beads, DNA, and CTAB is: 1-5:25-50:10-20; preferably: 1:25:20;

[0012] The mass concentration of the gold nanoparticles is 0.02-0.1 mg / mL, preferably 0.08 mg / mL.

[0013] Further, the DNA is 5'-biotin-modified DNA;

[0014] The sequence of the DNA is shown as SEQ ID No.1.

[0015] The present invention provides an endotoxin sensing detection method, which measures the endotoxin content based on the color change of gold nanoparticles on a test paper mediated by a cationic surfactant, cetyltrimethylammonium bromide (CTAB). When endotoxin exists in a sample, the gold nanoparticles are coated by the surfactant and aggregated under the action of the surfactant. Due to the unique optical properties of the gold nanoparticles, the color of the solution changes from red to blue. The accurate quantitative detection of endotoxin can be achieved by combining the depth of color with the fluorescence spectrum.

[0016] The endotoxin sensing detection method of the present invention comprises the following steps:

[0017] Step 1: Take the magnetic bead solution, adsorb the magnetic beads with a magnet, remove the supernatant, add DNA and incubate at 37°C, wash with HEPES to remove residual DNA, and remove the supernatant;

[0018] Step 2: Add the sample solution containing endotoxin to the magnetic bead solution in step 1 and incubate at 37°C. Remove the supernatant and add a solution of hexadecyltrimethylammonium bromide (CTAB) and incubate at 37°C. Collect the supernatant into another centrifuge tube.

[0019] Step 3: Add AuNPs to the centrifuge tube in step 2, observe the color change, and determine the endotoxin content by fluorescence spectroscopy.

[0020] Alternatively, the supernatant collected in step 2 was added dropwise to the portable paper-based device containing the AuNPs reaction site, and after waiting for 3 minutes for the reaction, a photo was taken and recorded for analysis.

[0021] In the step 1, the DNA is 5'-biotin-modified DNA, and the sequence is shown in SEQ ID No. 1: AAAAAAAAAAAACCTTCTAACAGAATGTTGTTAGATAGCAAAAAAAAAAAACCTTCTA ACAGAATGTTGTTAGATAGC

[0022] In the step 1, the molar concentration of the magnetic bead solution is 0.1 to 0.5 μM;

[0023] In the step 1, the molar concentration of DNA is 0.5 to 10 μM, preferably 2.5 to 5 μM;

[0024] In the step 2, the molar concentration of hexadecyltrimethylammonium bromide is 5nM to 25μM, preferably 1 to 4μM, and more preferably 1 to 2μM;

[0025] In step 3, the portable paper-based device is a portable paper-based device assembled by sequentially arranging waterman filter paper, absorbent paper, and glass plate from top to bottom. AuNPs reaction sites are dropped on the waterman filter paper, and the reaction sites may be one or more.

[0026] In the step three, the mass concentration of the AuNPs is 0.02-0.1 mg / mL, preferably 0.08 mg / mL.

[0027] The present invention also provides a portable paper-based device for endotoxin sensing and detection, wherein the portable paper-based device is assembled by arranging waterman filter paper, absorbent paper, and a glass plate in order from top to bottom. The bonding method is to use solid glue or glue to stick the four corners of the absorbent paper to the glass plate.

[0028] AuNPs reaction sites are dropped on the waterman filter paper. The reaction sites can be one or more. The schematic diagram of its structure is shown in Figure 4 The structural anatomy diagram is shown in Figure 5 shown.

[0029] Compared with the prior art, the present invention uses hexadecyltrimethylammonium bromide-mediated gold nanoparticles for the detection of endotoxins, and designs the gold nanoparticles into a paper-based colorimetric sensor. The device is not only small and portable, but also no longer completely relies on laboratory ultraviolet absorption spectrum measurement to collect and analyze optical signals, thus overcoming the application limitation of large-scale equipment for rapid on-site detection. The device also has high sensitivity, thus achieving the purpose of accurate quantitative detection of endotoxins, with a minimum detection limit of 1.890 μM. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 This is a schematic diagram of the endotoxin sensing detection principle of the present invention;

[0031] Figure 2 The sensing detection results of detection reagents with different compositions;

[0032] (A) Color changes of gold nanoparticles with different reagent compositions;

[0033] I: AuNPs+MB II: AuNPs+MB+DNAIII: AuNPs+MB+DNA+CTAB

[0034] IV: AuNPs+MB+DNA+CTAB+LPS

[0035] (B) UV absorption spectra under compositions I, II, III, and IV;

[0036] (C) Absorbance ratio at 650 nm and 520 nm for compositions I, II, III, and IV;

[0037] Figure 3 is the relationship between LPS concentration and the color change of paper base site (BG / R);

[0038] A: Relationship curve between LPS and BG / R at different concentrations. B: Standard curve of LPS at 2-8 μM concentration.

[0039] Figure 4 It is a schematic diagram of the structure of the paper-based device in the present invention;

[0040] 1. Glass plate; 2. Absorbent paper; 3. Waterman filter paper; 4. Reaction site.

[0041] Figure 5 It is a schematic diagram of the structural anatomy of the paper-based device in the present invention.

[0042] Figure 6 This is a diagram showing the color change of drinking water detected by the paper-based colorimetric sensor in Example 5. DETAILED DESCRIPTION

[0043] Example 1 Color changes of gold nanoparticles under different reagent composition conditions:

[0044] The composition of reagents I-IV is as follows:

[0045] Group I: gold nanoparticles and magnetic beads;

[0046] Group II: gold nanoparticles, magnetic beads, and DNA;

[0047] Group III: gold nanoparticles, magnetic beads, DNA, and CTAB;

[0048] Group IV: gold nanoparticles, magnetic beads, DNA, CTAB and LPS.

[0049] The experimental methods of each group are as follows:

[0050] Group I:

[0051] Step 1: Take 100 μL of the washed 0.1 μM magnetic bead solution, adsorb the magnetic beads with a magnet, wash with HEPES, and remove the supernatant.

[0052] Step 2: Add AuNPs to the magnetic beads in step 1, and the mass concentration of AuNPs is 0.08 mg / mL.

[0053] Group II:

[0054] Step 1: Take 100 μL of the washed 0.1 μM magnetic bead solution, adsorb the magnetic beads with a magnet, remove the supernatant, add 100 μL of 2.5 μM 5'-biotin-modified DNA and incubate at 37°C for 15 min, adsorb the magnetic beads with a magnet, wash with HEPES to remove residual DNA, and remove the supernatant.

[0055] Step 2: Add AuNPs to the magnetic beads in step 1, and the mass concentration of AuNPs is 0.08 mg / mL.

[0056] Group III:

[0057] Step 1: Take 100 μL of the washed 0.1 μM magnetic bead solution, adsorb the magnetic beads with a magnet, remove the supernatant, add 100 μL of 2.5 μM 5'-biotin-modified DNA and incubate at 37°C for 15 min, adsorb the magnetic beads with a magnet, wash with HEPES to remove residual DNA, and remove the supernatant.

[0058] Step 2: Add 200 μL of 1 μM CTAB aqueous solution to the magnetic beads in step 1 and incubate at 37°C for 10 min. Collect 100 μL of the supernatant into a 1.5 ml centrifuge tube.

[0059] Step 3: Add AuNPs to the centrifuge tube in step 2, with a mass concentration of AuNPs of 0.08 mg / mL.

[0060] Group IV:

[0061] Step 1: Take 100 μL of the washed 0.1 μM magnetic bead solution, adsorb the magnetic beads with a magnet, remove the supernatant, add 100 μL of 2.5 μM 5'-biotin-modified DNA and incubate at 37°C for 15 min, adsorb the magnetic beads with a magnet, wash with HEPES to remove residual DNA, and remove the supernatant.

[0062] Step 2: Add 100 μL of LPS 100 μM solution to the magnetic bead solution and incubate at 37°C for 10 min. Remove the supernatant and add 200 μL of 1 μM CTAB aqueous solution and incubate at 37°C for 10 min. Collect 100 μL of the supernatant into a 1.5 ml centrifuge tube.

[0063] Step 3: Add AuNPs to the centrifuge tube in step 2, and the mass concentration of AuNPs is 0.08 mg / mL.

[0064] Example 2

[0065] The color changes of the reagents of each group I-IV in Example 1 were observed, the ultraviolet absorption peak positions of samples of different colors were determined, and the absorbance ratio of each group of samples at 650 nm and 520 nm was calculated.

[0066] The results showed that groups Ⅰ, Ⅱ, and Ⅲ all showed red color, while group Ⅳ showed blue color. Figure 2 (A) shown.

[0067] The UV spectrum results show that the red absorption peak is at 520nm, while the blue absorption peak is at 650nm. Figure 2 (B) shown.

[0068] In order to compare the color changes more accurately, the absorbance ratio of each group at 650nm and 520nm, i.e. A650 / A520, was analyzed in detail. Figure 2 (C) shown.

[0069] Conclusion: Only when gold nanoparticles, magnetic beads, DNA, CTAB and LPS coexist in the reagent, gold nanoparticles will aggregate and the color will change from red to blue, and LPS plays a key role in this. When the reagent does not contain LPS, gold nanoparticles will not aggregate and the color will remain red. According to the property that the color of gold nanoparticles changes from red to blue in a specific reagent containing LPS, it is possible to consider using a reagent composed of gold nanoparticles, magnetic beads, DNA and CTAB to detect LPS. LPS is the main component of endotoxin, so this method can be used for endotoxin detection.

[0070] Example 3 Effect of LPS concentration on test results

[0071] Referring to the method of Group IV of Example 1, the concentrations of LPS were changed to 0, 0.01 μM, 0.5 μM, 2 μM, 4 μM, 5 μM, 6 μM, 8 μM, and 10 μM. The effect of LPS concentration on the test results was investigated. The results are shown in Figure 3 (A).

[0072] The results showed that when the concentration of LPS was between 2 and 8 μM, BG / R was linearly related to LPS concentration, and the linear equation was Y=3.78X+100.52, R 2 =0.99913. See the results Figure 3 (B).

[0073] Example 4 Preparation of portable paper-based devices

[0074] The portable paper-based device was assembled by arranging waterman filter paper, absorbent paper, and glass plate in order from top to bottom. Ten AuNPs reaction sites were dropped on the waterman filter paper.

[0075] The portable paper-based device comprises a glass plate 1, an absorbent paper 2 is overlapped and adhered to the upper end of the glass plate 1, a waterman filter paper 3 is overlapped and adhered to the upper end of the absorbent paper 2, and 10 AuNPs reaction sites 4 are dropped on the upper end of the waterman filter paper 3.

[0076] The glass plate 1 is 7.5 cm long and 2.5 cm wide.

[0077] The absorbent paper 2 is produced by Shanghai Jinbiao Biotechnology Co., Ltd. and is cut to a size of 7.5 cm in length and 2.5 cm in width.

[0078] The waterman filter paper 3 is produced by Global Life Sciences Solutions Operations UK Ltd and is cut to a size of 7.5 cm in length and 2.5 cm in width.

[0079] The reaction site 4 has a diameter of 0.5 cm.

[0080] The method of dropping AuNPs into the reaction site is: dropping 1uL AuNPs at a time, and dropping continuously for 50 times, with a total amount of 50uL AuNPs.

[0081] Example 5: Portable paper-based device for detecting endotoxins in drinking water:

[0082] Step 1: Take 100 μL of the washed 0.1 μM magnetic bead solution, adsorb the magnetic beads with a magnet, remove the supernatant, add 100 μL of 2.5 μM 5'-biotin-modified DNA and incubate at 37°C for 15 min, adsorb the magnetic beads with a magnet, wash with HEPES to remove residual DNA, and remove the supernatant.

[0083] Step 2: Add 100 μL of drinking water to the magnetic bead solution and incubate at 37°C for 10 min. Remove the supernatant and add 200 μL of 1 μM CTAB aqueous solution and incubate at 37°C for 10 min. Collect 100 μL of the supernatant into a 1.5 ml centrifuge tube.

[0084] Step 3: Add the supernatant collected in step 2 dropwise to the portable paper-based device containing the AuNPs reaction site (Example 4), wait for 3 minutes for the reaction, and then take photos and record for analysis.

[0085] Figure 6 The effect of the paper-based colorimetric sensor in detecting actual drinking water is shown. It can be clearly seen that different concentrations of LPS can be clearly distinguished by color on the paper-based sensor. The following table is obtained after data analysis and calculation of the color development sites in the figure, which determines that the recovery rate of this method in the detection of endotoxin content in drinking water is between 100.77% and 124.93%, indicating that this detection method has a high accuracy in the determination of LPS content in practical applications.

[0086] Table 1 Analysis of drinking water test results

[0087]

Claims

1. An endotoxin sensing detection reagent, It is characterized in that The invention is composed of gold nanoparticles, magnetic beads, DNA and hexadecyltrimethylammonium bromide. The molar ratio of the magnetic beads, DNA and hexadecyltrimethylammonium bromide is 1-5:25-50:10-20. The mass concentration of the gold nanoparticles is 0.02-0.1 mg / mL.

2. The endotoxin sensing detection reagent according to claim 1, It is characterized in that The DNA is 5'-biotin-modified DNA.

3. An endotoxin sensing detection method, It is characterized in that The steps include: Step 1: Take the magnetic bead solution, adsorb the magnetic beads with a magnet, remove the supernatant, add DNA and incubate at 37°C, adsorb the magnetic beads with a magnet, wash with HEPES to remove the residual DNA, and remove the supernatant; Step 2: Add the sample solution to the magnetic bead solution in step 1, incubate at 37°C, remove the supernatant, add hexadecyltrimethylammonium bromide aqueous solution, incubate at 37°C, and collect the supernatant into another centrifuge tube; Step 3: Add AuNPs to the centrifuge tube in step 2, observe the color change, and determine the endotoxin content by fluorescence spectroscopy. Alternatively, the supernatant collected in step 2 is added dropwise to the portable paper-based device containing the AuNPs reaction site, and after waiting for the reaction, a photo is taken and recorded for analysis.

4. The method according to claim 3, It is characterized in that In the step 1, the DNA is 5'-biotin-modified DNA.

5. The method according to claim 3, It is characterized in that In the step 1, the molar concentration of the magnetic bead solution is 0.1-0.5 μM; the molar concentration of DNA is 0.5-10 μM, preferably 2.5-5 μM.

6. The method according to claim 3, It is characterized in that In the step 2, the molar concentration of hexadecyltrimethylammonium bromide is 5 nm to 25 μM, preferably 1 to 4 μM.

7. The method according to claim 3, It is characterized in that In the step three, the mass concentration of the AuNPs is 0.08 mg / mL.

8. The method according to claim 3, It is characterized in that In step three, the portable paper-based device is a portable paper-based device assembled in the order of waterman filter paper, absorbent paper, and glass plate from top to bottom, and AuNPs reaction sites are dropped on the waterman filter paper, and the reaction sites can be one or more.

9. A portable paper-based device for endotoxin sensing detection, It is characterized in that The waterman filter paper, absorbent paper and glass plate are assembled in sequence from top to bottom, and AuNPs reaction sites are dropped on the waterman filter paper, and the reaction sites may be one or more.

10. Use of the endotoxin sensing detection reagent according to claim 1 or 2, the endotoxin sensing detection method according to any one of claims 3 to 8, or the portable paper-based device for endotoxin sensing detection according to claim 9 in endotoxin detection.